Concepedia

Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial

Hirohisa Saito, Hirohisa Yoshizawa, Kozo Yoshimori, Nobuyuki Katakami, Noriyuki Katsumata, Minoru Kawahara, Katsumi Eguchi

Annals of Oncology · 2012 · 118 citations · 16 references

DOIFull text

Open access

Concepts

References

16

Hepatobiliary Cancers

Al B. Benson, Thomas A. Abrams, Edgar Ben‐Josef et al. · Journal of the National Comprehensive Cancer Network · 2009 · 2.3K citations · Full text

, , +14

The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group

Paul J. Hesketh, Steven M. Grunberg, Richard J. Gralla et al. · Journal of Clinical Oncology · 2003 · 776 citations

, , +17

American Society of Clinical Oncology Guideline for Antiemetics in Oncology: Update 2006

Mark G. Kris, Paul J. Hesketh, Mark R. Somerfield et al. · Journal of Clinical Oncology · 2006 · 743 citations · Full text

, , +15

Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy‐induced nausea and vomiting

S. Poli-Bigelli, José Rodrigues-Pereira, Alexandra D. Carides et al. · Cancer · 2003 · 566 citations

, , +17

Incidence of chemotherapy‐induced nausea and emesis after modern antiemetics

Steven M. Grunberg, Robert Deuson, Panagiotis Mavros et al. · Cancer · 2004 · 470 citations · Full text

, , +15